Researcher
Koen Raemdonck
- Disciplines:Nanobiotechnology, Environmental safety and health of nanotechnology, Nanoscale characterisation, Nanophotonics, Nanotechnology not elsewhere classified, Nanometrology, Drug discovery and development not elsewhere classified, Clinical trials, Other pharmaceutical sciences not elsewhere classified, Compound screening, In vitro testing, Biopharmaceuticals, Non-clinical studies, Molecular medicine, Vaccines, Nanomaterials, Nanomanufacturing, Nanofabrication, growth and self assembly, Nanoelectromechanical systems
Affiliations
- Department of Pharmaceutics (Department)
Member
From1 Oct 2004 → Today
Infrastructure
1 - 1 of 1
- Confocal and two-photon Microscope (Consortium partner)
Projects
1 - 10 of 18
- Exploring co-encapsulation of antihistamines and immune checkpoint siRNAs in lipid nanoparticles for cancer immunotherapy.From1 Oct 2023 → TodayFunding: BOF - doctoral mandates
- Conformationally locked G4-decoy oligonucleotides for selective telomerase inhibition and development of a nucleic acid-based anti-telomerase PROTAC strategyFrom1 Oct 2022 → TodayFunding: FWO junior postdoctoral fellowship
- Synthesis of modified PNA probes for sequence-selective G-quadruplex photoalkylation.From1 Nov 2021 → TodayFunding: FWO Strategic Basic Research Grant
- REpurposing lung Surfactant Protein B for Inhalation therapy with RNA therapeuticsFrom1 May 2021 → TodayFunding: H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)
- Repurposing lung surfactant protein B for inhalation therapy with RNA therapeuticsFrom1 Nov 2020 → TodayFunding: FWO Strategic Basic Research Grant
- Stimulated emission depletion microscopy (STED): Nanoscopy for innovative research in the life sciencesFrom1 May 2020 → TodayFunding: FWO Medium Size Research Infrastructure
- NANOMED / Colloidally stable nanogel formulations for siRNA deliveryFrom1 Aug 2019 → 31 Jan 2020Funding: BOF - doctoral mandates
- Local immunomodulation of atherosclerosis by CD8+ T-cell based nanomedicinesFrom1 May 2019 → 30 Apr 2022Funding: FWO research project (including WEAVE projects)
- RNA-MAGIC: RNA-based bioMArkers and tarGets In asthma and Chronic Obstructive Pulmonary Disease (COPD)From1 Jan 2019 → TodayFunding: BOF - projects
- Combination cancer therapy by simultaneous delivery of cationic amphiphilic drugs and RNA therapeutics using a polymer delivery platformFrom1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
Publications
31 - 40 of 87
- Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells(2018)
Authors: Freya Joris, Lynn De Backer, Thijs Van de Vyver, Chiara Bastiancich, Koen Raemdonck
Pages: 266 - 276 - Intracellular delivery of oligonucleotides in Helicobacter pylori by fusogenic liposomes in the presence of gastric mucus(2017)
Authors: Rita Sobral Fernandes Machado dos Santos, George Dakwar, Elisa Zagato, Toon Brans, Céu Figueiredo, Koen Raemdonck, Nuno F Azevedo, Kevin Braeckmans
Pages: 1 - 12 - Small molecules convey big messages : boosting non-viral nucleic acid delivery with low molecular weight drugs(2017)
Authors: Freya Joris, Koen Raemdonck
Pages: 14 - 29 - Comparing photoporation and nucleofection for delivery of small interfering RNA to cytotoxic T cells(2017)
Authors: Laura Wayteck, Kevin Braeckmans, Koen Raemdonck
Pages: 154 - 162 - Membrane vesicle secretion and prophage induction in multidrug-resistant Stenotrophomonas maltophilia in response to ciprofloxacin stress(2017)
Authors: Simon Devos, Wouter Van Putte, Jolien Vitse, Gonzalez Van Driessche, Stephan Stremersch, Koen Raemdonck, Kevin Braeckmans, Henning Stahlberg, Misha Kudryashev, Savvas Savvides, et al.
Pages: 3930 - 3937 - Choose your cell model wisely : the in vitro nanoneurotoxicity of differentially coated iron oxide nanoparticles for neural cell labeling(2017)
Authors: Freya Joris, Daniel Valdepérez, Beatriz Pelaz, Tianqiang Wang, Shareen H. Doak, Bella B. Manshian, Stefaan J. Soenen, Wolfgang J. Parak, Koen Raemdonck
Pages: 204 - 213 - Characterization data on the topical carrier DDC642(2016)
Authors: Eline Desmet, Stefanie Bracke, Katrien Forier, Lien Taevernier, Marc CA Stuart, Bart De Spiegeleer, Koen Raemdonck, Mireille Van Gele
Pages: 1204 - 1210 - The impact of species and cell type on the nanosafety profile of iron oxide nanoparticles in neural cells(2016)
Authors: Freya Joris, Daniel Valdepérez, Beatriz Pelaz, Stefaan J Soenen, Bella B Manshian, Wolfgang J Parak, Koen Raemdonck
- Identification of a novel mechanism of blood-brain communication during peripheral inflammation via choroid plexus-derived extracellular vesicles(2016)
Authors: Sriram Balusu, Elien Van Wonterghem, Koen Raemdonck, Stephan Stremersch, Delphine Demeestere, Valerie Vanhooren, An Hendrix, Claude Libert
Pages: 1162 - 1183 - Hitchhiking nanoparticles: reversible coupling of lipid-based nanoparticles to cytotoxic T lymphocytes(2016)
Authors: Laura Wayteck, Heleen Dewitte, Lynn De Backer, Karine Breckpot, Koen Raemdonck
Pages: 243 - 254
Patents
1 - 7 of 7
- MOLECULAR ADJUVANTS FOR ENHANCED CYTOSOLIC DELIVERY OF ACTIVE AGENTS (Inventor)
- PARTICLES COMPRISING SURFACTANT PROTEIN B AND ONE OR MORE LIPIDS (Inventor)
- Method and system for characterizing extracellular vesicles (Inventor)
- Method and system for characterizing extracellular vesicles (Inventor)
- PARTICLES COMPRISING SURFACTANT PROTEIN B AND ONE OR MORE LIPIDS (Inventor)
- MOLECULAR ADJUVANTS FOR ENHANCED CYTOSOLIC DELIVERY OF ACTIVE AGENTS (Inventor)
- PARTICLES COMPRISING SURFACTANT PROTEIN B AND ONE OR MORE LIPIDS (Inventor)